110 related articles for article (PubMed ID: 36883368)
1. Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment.
Garmendia I; Varthaman A; Marmier S; Angrini M; Matchoua I; Darbois-Delahousse A; Josseaume N; Foy PE; Roumenina LT; Naouar N; Meylan M; Sibéril S; Russick J; Joubert PE; Leroy K; Damotte D; Mansuet-Lupo A; Wislez M; Alifano M; Menger L; Garcia-Verdugo I; Sallenave JM; Lantz O; Petitprez F; Cremer I
Cancer Immunol Res; 2023 Apr; 11(4):530-545. PubMed ID: 36883368
[TBL] [Abstract][Full Text] [Related]
2. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
[TBL] [Abstract][Full Text] [Related]
3. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
4. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
[TBL] [Abstract][Full Text] [Related]
5. Progesterone-Based Contraceptives Reduce Adaptive Immune Responses and Protection against Sequential Influenza A Virus Infections.
Hall OJ; Nachbagauer R; Vermillion MS; Fink AL; Phuong V; Krammer F; Klein SL
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179523
[TBL] [Abstract][Full Text] [Related]
6. Cellular Heterogeneity and Molecular Reprogramming of the Host Response during Influenza Acute Lung Injury.
Guo K; Yombo DJK; Schmit T; Wang Z; Navaeiseddighi Z; Sathish V; Mathur R; Wu M; Kumar B; Hur J; Khan N
J Virol; 2022 Nov; 96(21):e0124622. PubMed ID: 36286482
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
8. Inducible general knockout of Runx3 profoundly reduces pulmonary cytotoxic CD8
Hao Q; Kundu S; Shetty S; Tucker TA; Idell S; Tang H
Front Immunol; 2022; 13():1011922. PubMed ID: 36275778
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell NLRC4 regulates influenza A virus-specific CD4 T cell responses through FasL expression.
Hornick EE; Dagvadorj J; Zacharias ZR; Miller AM; Langlois RA; Chen P; Legge KL; Bishop GA; Sutterwala FS; Cassel SL
J Clin Invest; 2019 Apr; 129(7):2888-2897. PubMed ID: 31038471
[TBL] [Abstract][Full Text] [Related]
10. Alveolar Type II Epithelial Cells Contribute to the Anti-Influenza A Virus Response in the Lung by Integrating Pathogen- and Microenvironment-Derived Signals.
Stegemann-Koniszewski S; Jeron A; Gereke M; Geffers R; Kröger A; Gunzer M; Bruder D
mBio; 2016 May; 7(3):. PubMed ID: 27143386
[TBL] [Abstract][Full Text] [Related]
11. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control.
Steinbach P; Pastille E; Kaumanns L; Adamczyk A; Sutter K; Hansen W; Dittmer U; Buer J; Westendorf AM; Knuschke T
PLoS Pathog; 2024 Jan; 20(1):e1011982. PubMed ID: 38271469
[TBL] [Abstract][Full Text] [Related]
13. Silent Infection of B and CD8
Castro IA; Jorge DMM; Ferreri LM; Martins RB; Pontelli MC; Jesus BLS; Cardoso RS; Criado MF; Carenzi L; Valera FCP; Tamashiro E; Anselmo-Lima WT; Perez DR; Arruda E
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075928
[TBL] [Abstract][Full Text] [Related]
14. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
[TBL] [Abstract][Full Text] [Related]
15. Chronic ethanol exposure selectively inhibits the influenza-specific CD8 T cell response during influenza a virus infection.
Hemann EA; McGill JL; Legge KL
Alcohol Clin Exp Res; 2014 Sep; 38(9):2403-13. PubMed ID: 25160044
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation.
Zhang B; Zeng J; Zhang H; Zhu S; Wang H; He J; Yang L; Zhou N; Zu L; Xu X; Song Z; Xu S
Front Immunol; 2022; 13():974581. PubMed ID: 36159860
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
[TBL] [Abstract][Full Text] [Related]
18. Evodiamine suppresses non-small cell lung cancer by elevating CD8
Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL
J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183
[TBL] [Abstract][Full Text] [Related]
19. Chronic Ethanol Consumption Reduces Existing CD8 T Cell Memory and Is Associated with Lesions in Protection against Secondary Influenza A Virus Infections.
Zacharias ZR; Legge KL
J Immunol; 2019 Dec; 203(12):3313-3324. PubMed ID: 31712384
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Programmed Cell Death Protein 1/Programmed Cell Death Ligand 1 Expression Induced by Severe Influenza A Virus Infection Impairs Host's Antiviral Response.
Ou H; Chen L; Wu H
Viral Immunol; 2022 Oct; 35(8):566-576. PubMed ID: 36094816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
